Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1062114

registered interest
date	15/02/2019
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, for what reason her Department requires owners of limited companies to provide company financial accounts when applying for universal credit; and if she will review that policy.
tabling member constituency	Motherwell and Wishaw
tabling member printed	Marion Fellows
uin	222036
answer	answer is ministerial correction date of answer 20/02/2019 answer text <p>The Department does not require owners of limited companies to provide company financial accounts when applying for Universal Credit. Self-employed earnings are reported on a simplified 'cash accounting' basis, which asks for the total income from receipts into the business and details of payments out of the business under defined categories during the assessment period. The requirements were designed to be as simple as possible in order for self-employed claimants to easily report their earnings.</p><p> </p><p>The Department has therefore not made an assessment.</p> answering member constituency Reading West answering member printed Alok Sharma grouped question UIN 222037 question first answered 20/02/2019 17:36:18 answering member 4014 label Biography information for Sir Alok Sharma
tabling member	4440 label Biography information for Marion Fellows

175736

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Muscular Dystrophy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the Government plans to commission Translarna during NHS England's public consultations on its principles and approach to decision making on drug licensing.
tabling member constituency	Blaydon
tabling member printed	Mr David Anderson
uin	222036
answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>Translarna (ataluren) was given conditional approval for the treatment of Duchenne Muscular Dystrophy by the European Medicines Agency in August 2014.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for commissioning treatments for specialised services.</p><p> </p><p> </p><p> </p><p>At its Board meeting on 17 December, NHS England decided that the consultation on prioritisation for specialised services should be 90 days. The length of the consultation period reflects the importance of these decisions and advice received from patient groups. Decisions on prioritisation, including the advice from the Clinical Priorities Advisory Group on the routine commissioning of Translarna (ataluren), will not be completed until the consultation has closed and the consultation responses have had due consideration. NHS England launched the consultation on 27 January 2015 and it is open for responses until 27 April 2015.</p><p> </p><p> </p><p> </p><p>Any prioritisation which is urgent on clinical grounds will continue to be dealt with quickly through NHS England’s existing procedures. The route of individual funding requests remains the same.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 222037 222038 question first answered 02/02/2015 16:35:40 answering member 3918 label Biography information for Jane Ellison
tabling member	1486 label Biography information for Mr David Anderson

175740

registered interest
date	26/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for how long NHS England's public consultations about the principles and approach to decision making on drug licensing will last.
tabling member constituency	Blaydon
tabling member printed	Mr David Anderson
uin	222038
answer	answer is ministerial correction date of answer 02/02/2015 answer text <p>Translarna (ataluren) was given conditional approval for the treatment of Duchenne Muscular Dystrophy by the European Medicines Agency in August 2014.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for commissioning treatments for specialised services.</p><p> </p><p> </p><p> </p><p>At its Board meeting on 17 December, NHS England decided that the consultation on prioritisation for specialised services should be 90 days. The length of the consultation period reflects the importance of these decisions and advice received from patient groups. Decisions on prioritisation, including the advice from the Clinical Priorities Advisory Group on the routine commissioning of Translarna (ataluren), will not be completed until the consultation has closed and the consultation responses have had due consideration. NHS England launched the consultation on 27 January 2015 and it is open for responses until 27 April 2015.</p><p> </p><p> </p><p> </p><p>Any prioritisation which is urgent on clinical grounds will continue to be dealt with quickly through NHS England’s existing procedures. The route of individual funding requests remains the same.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 222036 222037 question first answered 02/02/2015 16:35:40 answering member 3918 label Biography information for Jane Ellison
tabling member	1486 label Biography information for Mr David Anderson